LETHAL STAPHYLOCOCCUS-AUREUS-INDUCED SHOCK IN PRIMATES - PREVENTION OF DEATH WITH ANTI-TNF ANTIBODY

被引:111
作者
HINSHAW, LB
EMERSON, TE
TAYLOR, FB
CHANG, ACK
DUERR, M
PEER, GT
FLOURNOY, DJ
WHITE, GL
KOSANKE, SD
MURRAY, CK
XU, R
PASSEY, RB
FOURNEL, MA
机构
[1] CUTTER BIOL MILES INC,BERKELEY,CA
[2] UNIV OKLAHOMA,NORMAN,OK 73019
[3] OKLAHOMA MEM HOSP & CLIN,OKLAHOMA CITY,OK
关键词
D O I
10.1097/00005373-199210000-00013
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A successful experimental treatment for gram-positive sepsis to our knowledge has not been achieved. The objectives of this study were to develop a nonhuman primate model of lethal gram-positive sepsis employing the micro-organism Staphylococcus aureus and to determine the efficacy of treatment using monoclonal antibody (MAb) to tumor necrosis factor alpha (TNF). The antibody was administered intravenously, 15 mg/kg, 30 minutes after the beginning of a 2-hour infusion of S. aureus, 4 x 10(10) colony forming units/kilogram. The baboons infused with S. aureus demonstrated the release of the cytokines TNF and interleukin-6 (IL-6), but endotoxin was not observed in the plasma at any time. Treatment with antibody to TNF abolished the rise in serum TNF levels and reduced the increased levels of IL-6. Treatment with MAb to TNF prevented multiple organ failure and achieved permanent (>7 day) survival of all baboons.
引用
收藏
页码:568 / 573
页数:6
相关论文
共 20 条
  • [1] TUMOR-NECROSIS-FACTOR AND SEPTIC SHOCK
    BAUD, L
    CADRANEL, J
    OFFENSTADT, G
    LUQUEL, L
    GUIDET, B
    AMSTUTZ, P
    [J]. CRITICAL CARE MEDICINE, 1990, 18 (03) : 349 - 350
  • [2] A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK
    BONE, RC
    FISHER, CJ
    CLEMMER, TP
    SLOTMAN, GJ
    METZ, CA
    BALK, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) : 653 - 658
  • [3] PLASMA TUMOR NECROSIS FACTOR AND MORTALITY IN CRITICALLY ILL SEPTIC PATIENTS
    DEBETS, JMH
    KAMPMEIJER, R
    VANDERLINDEN, MPMH
    BUURMAN, WA
    VANDERLINDEN, CJ
    [J]. CRITICAL CARE MEDICINE, 1989, 17 (06) : 489 - 494
  • [4] A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES
    ESPEVIK, T
    NISSENMEYER, J
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) : 99 - 105
  • [5] ANTIBODIES TO CACHECTIN TUMOR NECROSIS FACTOR REDUCE INTERLEUKIN-1-BETA AND INTERLEUKIN-6 APPEARANCE DURING LETHAL BACTEREMIA
    FONG, YM
    TRACEY, KJ
    MOLDAWER, LL
    HESSE, DG
    MANOGUE, KB
    KENNEY, JS
    LEE, AT
    KUO, GC
    ALLISON, AC
    LOWRY, SF
    CERAMI, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) : 1627 - 1633
  • [6] FONG YM, 1989, J IMMUNOL, V142, P2321
  • [7] FUNCTIONAL DISCRIMINATION BETWEEN INTERLEUKIN-6 AND INTERLEUKIN-1
    HELLE, M
    BOEIJE, L
    AARDEN, LA
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (10) : 1535 - 1540
  • [8] HINSHAW LB, 1988, CIRC SHOCK, V26, P257
  • [9] HINSHAW LB, 1990, CIRC SHOCK, V30, P279
  • [10] EFFECTIVENESS OF STEROID-ANTIBIOTIC TREATMENT IN PRIMATES ADMINISTERED LD100 ESCHERICHIA-COLI
    HINSHAW, LB
    BELLERTODD, BK
    ARCHER, LT
    BENJAMIN, B
    FLOURNOY, DJ
    PASSEY, R
    WILSON, MF
    [J]. ANNALS OF SURGERY, 1981, 194 (01) : 51 - 56